Fig. 6From: Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancerDistribution of risk score, time dependent ROC curves at 1, 3 and 5 years and Kaplan–Meier survival analysis between low and high risk patients with or without adjuvant chemotherapy in the training set (a–c and g–i) and validation set (d–f and j–l)Back to article page